Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.82 INR | +0.10% |
|
-4.66% | +30.76% |
May. 30 | Hemo Organic Appoints CFO | MT |
May. 29 | Hemo Organic Limited Approves Appointment of Murlidhar Joshi as Chief Financial Officer | CI |
Sales 2022 | 68.3K 816.94 | Sales 2023 | 47.7K 570.54 | Capitalization | 24.61M 294K |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 2,607 x |
Net Debt 2022 | 258K 3.09K | Net cash position 2023 | 814K 9.74K | EV / Sales 2023 | 499 x |
P/E ratio 2022 |
-285
x | P/E ratio 2023 |
-45
x | Employees | 2 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
1 day | +0.10% | ||
1 week | -4.66% | ||
Current month | -12.01% | ||
1 month | -15.34% | ||
3 months | -1.01% | ||
6 months | +30.76% | ||
Current year | +30.76% |
![Extreme 9.6](/images/extremecours_fleche.png)
![Extreme 9.6](/images/extremecours_fleche.png)
![Extreme 6.44](/images/extremecours_fleche.png)
![Extreme 5.57](/images/extremecours_fleche.png)
![Extreme 5.57](/images/extremecours_fleche.png)
![Extreme 5.57](/images/extremecours_fleche.png)
![Extreme 5.57](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | Nov. 07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 37 | - | |
Chief Executive Officer | - | Nov. 07 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-21 | 9.82 | +0.10% | 3 930 |
24-06-20 | 9.81 | -3.06% | 690 |
24-06-19 | 10.12 | 0.00% | 1,710 |
24-06-18 | 10.12 | -1.75% | 2,369 |
24-06-14 | 10.3 | -2.46% | 2,353 |
Delayed Quote Bombay S.E., June 21, 2024 at 02:25 am EDT
More quotes- Stock Market
- Equities
- HEMORGANIC Stock